Intrathecal triple therapy decreases central nervous system relapse but fails to improve event-free survival when compared with intrathecal methotrexate: results of the Children's Cancer Group (CCG) 1952 study for standard-risk acute lymphoblastic l
about
Acute lymphoblastic leukaemiaA randomized, controlled, double-blind, pilot study of milk thistle for the treatment of hepatotoxicity in childhood acute lymphoblastic leukemia (ALL)Treating childhood acute lymphoblastic leukemia without cranial irradiationOral 6-mercaptopurine versus oral 6-thioguanine and veno-occlusive disease in children with standard-risk acute lymphoblastic leukemia: report of the Children's Oncology Group CCG-1952 clinical trial.Central nervous system disease in hematologic malignancies: historical perspective and practical applications.Long-term results of the children's cancer group studies for childhood acute lymphoblastic leukemia 1983-2002: a Children's Oncology Group Report.Improved prognosis for older adolescents with acute lymphoblastic leukemia.TPMT and MTHFR genotype is not associated with altered risk of thioguanine-related sinusoidal obstruction syndrome in pediatric acute lymphoblastic leukemia: a report from the Children's Oncology Group.Escalating intravenous methotrexate improves event-free survival in children with standard-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group.Treatment of pediatric acute lymphoblastic leukemia.Survivors of standard risk acute lymphoblastic leukemia do not have increased risk for overweight and obesity compared to non-cancer peers: a report from the Children's Oncology GroupRandomized trial of radiation-free central nervous system prophylaxis comparing intrathecal triple therapy with liposomal cytarabine in acute lymphoblastic leukemiaPrediction of outcome by early bone marrow response in childhood acute lymphoblastic leukemia treated in the ALL-BFM 95 trial: differential effects in precursor B-cell and T-cell leukemiaPediatric acute lymphoblastic leukemia: where are we going and how do we get there?Systematic review and meta-analysis of randomized trials of central nervous system directed therapy for childhood acute lymphoblastic leukemia.Outcome of Children with Standard-Risk T-Lineage Acute Lymphoblastic Leukemia--Comparison among Different Treatment StrategiesInfluence of Cranial Radiotherapy on Outcome in Children With Acute Lymphoblastic Leukemia Treated With Contemporary TherapyA 50-year journey to cure childhood acute lymphoblastic leukemiaComparison of neurocognitive functioning in children previously randomly assigned to intrathecal methotrexate compared with triple intrathecal therapy for the treatment of childhood acute lymphoblastic leukemia.The prognostic value of interim positron emission tomography scan in patients with classical Hodgkin lymphoma.Recent developments in the management of T-cell precursor acute lymphoblastic leukemia/lymphoma.Relapse of childhood acute lymphoblastic leukemia and outcomes at a reference center in Latin America: organomegaly at diagnosis is a significant clinical predictor.Off-therapy procedures are not beneficial in pediatric B-cell acute lymphoblastic leukemia.Does the early intensification of intrathecal therapy improve outcomes in pediatric acute lymphoblastic leukemia patients with CNS2/TLP+ status at diagnosis?Involvement of the cerebrospinal fluid cells in children with acute lymphoblastic leukemia: prognostic implications.Longitudinal language outcomes following intrathecal chemotherapy for acute lymphoblastic leukaemia.Tailored central nervous system-directed treatment strategy for isolated CNS recurrence of adult acute myeloid leukemia.Safety of intrathecal route: focus to methylprednisolone acetate (Depo-Medrol) use.The contribution of neurocognitive functioning to quality of life after childhood acute lymphoblastic leukemia.A pilot study of daunorubicin-augmented hyper-CVAD induction chemotherapy for adults with acute lymphoblastic leukemia.Age and high-dose methotrexate are associated to clinical acute encephalopathy in FRALLE 93 trial for acute lymphoblastic leukemia in children.Diagnosis of central nervous system relapse of pediatric acute lymphoblastic leukemia: Impact of routine cytological CSF analysis at the time of intrathecal chemotherapy.Investigation of the optimal duration of bed rest in the supine position to reduce complications after lumbar puncture combined with intrathecal chemotherapy: a multicenter prospective randomized controlled trial.Integrative computational in-depth analysis of dysregulated miRNA-mRNA interactions in drug-resistant pediatric acute lymphoblastic leukemia cells: an attempt to obtain new potential gene-miRNA pathways involved in response to treatment.
P2860
Q24602387-4121EC45-5334-4740-A287-D08204247247Q24633382-6A8606D8-A0BF-4833-AC0D-E8C6507B8B4CQ24644599-F59C9FBC-791E-4DF5-92DB-1F7B89155DC8Q33388076-527FE4EE-EE2B-41DA-9B7B-9FCEB9F3D2EAQ33585849-2433F5A1-2B8F-42B9-A588-37C901247807Q34003323-3AB90575-A9AD-4C1A-80CF-DE116751B0F8Q34679298-75EAD82F-248A-4766-813C-794785979A1DQ34812985-5054CFDE-149E-463F-9906-E28EE3FA9FF4Q35112206-2552DB57-DD39-4A43-AC4A-F8C2DEC1EFA0Q35196702-24117B6A-CEAD-48CA-BBEE-ADC9F68B38AAQ35513785-B94EF63A-C2AF-4DFA-9939-3CE2E6A3384DQ35669875-38996432-93E9-4686-AF92-7D29F6E59B65Q36094717-5F553290-5FCA-4FA9-8A58-2120780E3B1DQ36163029-9172FB58-0E95-4E50-8B06-917FD03E7528Q36287682-BDA0D30D-B6A2-46E5-813E-95E56FAC115EQ36469789-508B5A37-92BD-4368-BB72-1B9EDE181B4EQ36914357-6CA6EA00-F2E4-4AD6-B3AD-AE8DCF29D941Q37166753-3CE4390A-5186-46AF-A2C7-3AB2430FA56AQ37474408-99FAF5B7-F482-4B47-8DD5-7F4E3091DFEAQ37641042-48E9F58A-791C-40F0-B7C5-50C10402C673Q38000087-73A6EE7B-0351-4EFC-BF13-EC23EE595830Q38744187-68B8B105-ABBE-4AC1-8EFC-FC403F7C6FDEQ39194118-0E976437-4B70-4340-93AC-B3244953CB9EQ41717778-F3A4D40D-8B9C-48EA-8065-FB30D10C5B6FQ42282606-207B288C-5721-4C81-B0D5-0389FCD0905DQ44326589-2EB01AD6-25D9-4438-A928-2BD76A8BE246Q44772522-2C506C06-91C7-4793-95AB-3CB9C77C4C91Q47335987-170804E2-312E-4410-A829-4D00806D771FQ48086635-C38DD9A5-FA8B-4B2F-AB65-BDEB290343AAQ48320885-551A2C8B-FBE5-436A-B4E7-CECD80FF2410Q48337182-CC65F7A8-0331-468B-AF5A-51C891726AACQ48549419-5D50E500-34A9-4762-B5CD-986127603FADQ52652761-7401C33B-F012-4637-B747-F61440E1309BQ52893098-E73F9EBA-8B25-4FA6-8E38-D1F8FA087AAD
P2860
Intrathecal triple therapy decreases central nervous system relapse but fails to improve event-free survival when compared with intrathecal methotrexate: results of the Children's Cancer Group (CCG) 1952 study for standard-risk acute lymphoblastic l
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Intrathecal triple therapy dec ...... ard-risk acute lymphoblastic l
@ast
Intrathecal triple therapy dec ...... ard-risk acute lymphoblastic l
@en
type
label
Intrathecal triple therapy dec ...... ard-risk acute lymphoblastic l
@ast
Intrathecal triple therapy dec ...... ard-risk acute lymphoblastic l
@en
prefLabel
Intrathecal triple therapy dec ...... ard-risk acute lymphoblastic l
@ast
Intrathecal triple therapy dec ...... ard-risk acute lymphoblastic l
@en
P2093
P2860
P1433
P1476
Intrathecal triple therapy dec ...... ard-risk acute lymphoblastic l
@en
P2093
April D Sorrell
Children's Oncology Group
Emmett Broxson
Harland Sather
James Nachman
John F Kelleher
Linda C Stork
Linda M Wells
Margaret Masterson
Marilyn Blake
P2860
P304
P356
10.1182/BLOOD-2005-12-011809
P407
P577
2006-04-11T00:00:00Z